Overview
TLSI market data
Price History
TLSI price chart · 1M
- O
- 4.84
- H
- 5.11
- L
- 4.84
- C
- 4.94
- Vol
- 4,563.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $4.84
- Previous Close
- $4.94
- Day High
- $5.11
- Day Low
- $4.84
- 52 Week High
- $5.86
- 52 Week Low
- $2.23
- 7 Day Return
- -6.26%
- 30 Day Return
- +14.48%
- 90 Day Return
- +44.44%
- 1 Year Return
- +14.09%
- Daily Notional Volume
- $22.5K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.04 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.42 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -60.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.20 – $7.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $303.6M · P/B 5.02 · P/S 6.76.
Company News
TriSalus Life Sciences Affirms FY2026 Sales Guidance of $54.000M-$57.000M vs $52.396M EstBenzinga · Aug 6, 2026, 8:13 PM
TriSalus Life Sciences Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $11.407M Beat $10.267M EstimateBenzinga · Aug 6, 2026, 8:07 PM